Clinical Trial Update: Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating blinatumomab with autologous hematopoietic stem cell transplantation as consolidation therapy for B-cell acute lymphoblastic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (Blincyto) (blinatumomab)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING